KFAS
RMD icon

Keating Financial Advisory Services’s ResMed RMD Stock Holding History

Keating Financial Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Sell
629
-90
-13% -$22.4K 0.02% 397
2025
Q4 		$173K Buy
+719
New +$184K 0.02% 399

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Keating Financial Advisory Services's RMD Position: Q1 2026 in Review

Keating Financial Advisory Services reduced its ResMed (RMD) stake by 13% in Q1 2026, selling an estimated $22.4K and leaving 629 shares worth $141K. The position accounts for 0.02% of the portfolio, ranked #397.

Keating Financial Advisory Services first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $173K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Keating Financial Advisory Services held 629 shares of ResMed worth $141K as of Q1 2026.
  • Keating Financial Advisory Services sold 90 ResMed shares in Q1 2026, an estimated $22.4K.
  • ResMed made up 0.02% of Keating Financial Advisory Services's portfolio in Q1 2026, its #397 holding.
  • Keating Financial Advisory Services first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Keating Financial Advisory Services's ResMed position peaked at $173K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.